JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

A8464 LY2109761

4 Citation

Summary: TβRI/II kinase inhibitor

≥22.1 mg/mL
A5602 SB525334

Summary: (TGF-beta1) receptor inhibitor

≥34.3 mg/mL
A8348 LY2157299

2 Citation

Summary: TGF-βR1 inhibitor,potent and selective

insoluble in H2O; ≥18.45 mg/mL
A8301 GW788388

Summary: ALK5 inhibitor,potent and selective

≥21.25 mg/mL
A3133 A 83-01

Summary: ALK-5 inhibitor

≥21.1 mg/mL
A8232 Nilotinib(AMN-107)

1 Citation

Target: Bcr-Abl

Summary: Bcr-Abl kinase inhibitor,selective

≥26.5 mg/mL
A8604 GNF 5

Target: Bcr-Abl

Summary: Bcr-Abl inhibitor
A8249 SB 431542

2 Citation

Summary: ALK inhibitor
A5467 Ponatinib (AP24534)

1 Citation

Target: VEGFR|PDGFR|Bcr-Abl|FGFR|Src

Summary: pan-BCR-ABL inhibitor,multi-kinase inhibitor

≥53.3 mg/mL
A1670 Enzastaurin (LY317615)

2 Citation

Target: PKC

Summary: PKC beta inhibitor,potent and selective

insoluble in EtOH; insoluble in H2O; ≥8.59 mg/mL